| Malignant Histiocytic and Dendritic Cell Neoplasm studied in …STUDIED_INderived82 of 82show fewer |
|---|
| → studied in | NCT03779854Phase 2 · active not recruiting Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07785180recruiting A Non-interventional Study of Participants With BPDCN Treated With Chemotherapy · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04216524Phase 2 · recruiting Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06765876early Phase 1 · active not recruiting CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I Trial · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07819396Phase 2 · not yet recruiting Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03386513Phase 1/Phase 2 · active not recruiting Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06690827Phase 1 · recruiting Clinical Trial of CD123-targeted CAR-NK Therapy for Relapse/Refractory AML or BPDCN · condition mapped ALIAS · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07443137Phase 1 · not yet recruiting CAR-T ceLL for Eradication of Active Residual Disease in LBCL (CLEAR-1 Study) · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02159495Phase 1 · active not recruiting Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07785154recruiting A Registry-study of ELZONRIS in Participants With BPDCN · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07778212NA · recruiting Orelabrutinib Combined With Pola-R-CHP as First-Line Treatment for Patients With Intermediate- to High-Risk DLBCL · condition mapped PROBABILISTIC · 82 trials mapped (55 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04013685Phase 1 · active not recruiting Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07570823Phase 3 · recruiting A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03316573Phase 2 · suspended Pembrolizumab in Neoplasms or Lymphomas · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Histiocytic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07744724Phase 2 · not yet recruiting Pirtobrutinib+Pola-R-CHP for Newly Diagnosed Non-GCB DLBCL · condition mapped PROBABILISTIC · 82 trials mapped (55 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07744737Phase 2 · not yet recruiting Pirtobrutinib + R-CHOP for Untreated Non-GCB DLBCL · condition mapped PROBABILISTIC · 82 trials mapped (55 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07744750Phase 2 · not yet recruiting Pirtobrutinib+Sonrotoclax（PS) Regimen in the Treatment of B-Cell Lymphoma · condition mapped PROBABILISTIC · 82 trials mapped (55 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07749365Phase 2 · recruiting Hypofractionated Radiotherapy Plus GM-CSF, Pomalidomide and Glofitamab for Newly Diagnosed PCNS-DLBCL · condition mapped PROBABILISTIC · 82 trials mapped (55 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06006403Phase 1/Phase 2 · completed Safety and Efficacy of CD123-targeted CAR-NK for Relapsed/Refractory Acute Myeloid Leukemia or Blastic Plasmacytoid Dendritic Cell Neoplasm · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05362773Phase 1 · active not recruiting A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03155620Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Histiocytic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02523040Phase 2 · active not recruiting Lenalidomide for Adult Histiocyte Disorders · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Histiocytic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06013423Phase 2 · recruiting Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07680933Phase 2 · recruiting Orelabrutinib Combined With Standard Immunochemotherapy With or Without Autologous Hematopoietic Stem Cell Transplantation (Auto-HSCT) for Newly Diagnosed Diffuse Large B-cell Lymphoma (DLBCL) · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07007052Phase 2 · recruiting Phase II Study Evaluating the Efficacy and Safety of the Combination of Tagraxofusp and Venetoclax in Treatment-naive Blastic Plasmacytoid Dendritic Cell Neoplasm Patients · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07677813Phase 2 · not yet recruiting Orelabrutinib Combined With Induction Therapy Followed by Sequential Monotherapy Maintenance in MCD Subtype Diffuse Large B-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03113643Phase 1 · recruiting SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06985576enrolling by invitation Long-term Study to Evaluate Safety and Persistence of GF-CART01 · condition mapped PROBABILISTIC · 82 trials mapped (55 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06026644completed Health-Related Quality of Life Outcomes in Patients With Aggressive B-Cell Lymphomas Treated With CAR-T Cell Therapy in Real Life · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05430971recruiting Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02220985Phase 2 · completed Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04318678Phase 1 · recruiting CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML) · condition mapped ALIAS · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03326921Phase 1 · recruiting HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant · condition mapped CURATED_BROADER · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03246906Phase 2 · terminated Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07552324Phase 2 · not yet recruiting Study on the Treatment of Double/Triple-hit DLBCL With Chidamide and Lisaftoclax in Combination With Pola-R-CHP · condition mapped PROBABILISTIC · 82 trials mapped (55 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07511114Phase 3 · not yet recruiting A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyping · condition mapped PROBABILISTIC · 82 trials mapped (55 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06481826recruiting Glofitamab in Chinese Patients With R/R DLBCL · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07472621not yet recruiting Real-World Effectiveness and Safety of Glofitamab in Primary Refractory and Early Relapsed Diffuse Large B-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03404193Phase 2 · terminated Venetoclax and Decitabine in Treating Participants With Relapsed/Refractory Acute Myeloid Leukemia or Relapsed High-Risk Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07389356NA · not yet recruiting Modified R-MINE Regimen vs. R-GemOx Regimens on the Treatment of Late Relapsed DLBCL · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03485547Phase 1 · completed Study of Venetoclax, a BCL2 Antagonist, for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04681105Phase 1 · completed Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies · condition mapped CURATED_BROADER · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07288879Phase 2 · recruiting DALY II Japan/MB-CART2019.1 for DLBCL · condition mapped PROBABILISTIC · 82 trials mapped (55 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07326371Phase 2 · not yet recruiting Glofitamab Combined With CAR-T Therapy in R/R DLBCL · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05950802Phase 1 · recruiting Optimizing lymphoDepletion to Improve Outcomes In Patients Receiving Cell Therapy With Yescarta · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07255963Phase 2 · recruiting Pirtobrutinib, Lisaftoclax, and Rituximab in the Treatment of R/R DLBCL · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07231250Phase 2 · not yet recruiting Glofitamab Plus Polatuzumab Vedotin and Zuberitamab in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma · condition mapped PROBABILISTIC · 82 trials mapped (55 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06712810Phase 1 · recruiting Q702 for the Treatment of Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Histiocytic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05621096Phase 1 · active not recruiting Low Dose Radiation as Bridging Therapy in Relapsed B-Cell Non-Hodgkin Lymphoma · condition mapped PROBABILISTIC · 82 trials mapped (55 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04079179Phase 2 · recruiting Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Histiocytic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06592846completed FERtility After Therapy With Intensive Lymphoma in Young Women: LNH-03 1B, LNH-03 2B, LNH-07 3B, GAINED Follow-up · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07066436early Phase 1 · not yet recruiting ImmunoMRI for Assessment of Tumor-associated Macrophages · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07057765recruiting Predictive Value of CRP, Albumin, CAR, and mGPS in Treatment Outcomes of DLBCL · condition mapped PROBABILISTIC · 82 trials mapped (55 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07034508Phase 2 · not yet recruiting A Phase II Trial of 4 vs 6 Cycles of CHP Combined With Polatuzumab Vedotin-Rituximab in Untreated DLBCL Patients With IPI 0-1 · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06891157Phase 2 · recruiting Chidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular Subtypes · condition mapped PROBABILISTIC · 82 trials mapped (55 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06151080Phase 2 · recruiting Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL · condition mapped PROBABILISTIC · 82 trials mapped (55 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06158399Phase 2 · recruiting AZA Combined With RCHOP in P53-mutated DLBCL. · condition mapped PROBABILISTIC · 82 trials mapped (55 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06452446active not recruiting Telehealth-based Symptom Management for Veterans Treated With Selinexor · condition mapped PROBABILISTIC · 82 trials mapped (55 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06734078active not recruiting An Italian Multicenter Retrospective Observational Study to Assess the Clinical Characteristics and the Outcome of Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma Treated With Polatuzumab Vedotin Plus Rituximab (± Bendamustine) Under Named Patient Programme · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06026488recruiting Real-World Study of DLBCL With Different Genetic Subtypes · condition mapped PROBABILISTIC · 82 trials mapped (55 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05476770Phase 1 · recruiting Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies · condition mapped ALIAS · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05641428Phase 2 · recruiting Comparison of Point-of-care Produced CAR T-cell with Commercial CAR T-cells in Patients with R/R LBCL · condition mapped PROBABILISTIC · 82 trials mapped (55 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02113982Phase 1/Phase 2 · completed Tagraxofusp in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm or Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04317781Phase 2 · terminated Tagraxofusp in Treating Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm After Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06526065recruiting Molecular Mechanisms in Malignant Lymphoma- Predict (MMML Predict) · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04109482Phase 1/Phase 2 · terminated Trial to Evaluate the Safety and Efficacy of MB-102 in Patients With BPDCN. · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05645744terminated Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product. · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06299553recruiting Study to Evaluate the Effectiveness of Tafasitamab in Combination With Lenalidomide Followed by Tafasitamab Monotherapy in Relapsed or Refractory Diffuse Large B-cell Lymphoma Non-transplant Eligible Patients in Italy (PRO-MIND) · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03599960Phase 2 · unknown Combination Chemotherapy in Patients With Newly Diagnosed BPDCN · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02730312Phase 1 · completed PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03651375Phase 2 · unknown Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Histiocytic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03739606Phase 2 · withdrawn Flotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood Cancer · condition mapped CURATED_BROADER · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03974971completed Blastic Plasmacytoid Dendritic Cell Neoplasm in Korean Population. · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01593696Phase 1 · completed Anti-CD19 White Blood Cells for Children and Young Adults With B Cell Leukemia or Lymphoma · condition mapped PROBABILISTIC · 82 trials mapped (55 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03807063Phase 1 · withdrawn Rivogenlecleucel Donor Lymphocyte Immunotherapy in Treating Patients With Recurrent Blood Cancers After Stem Cell Transplant · condition mapped CURATED_BROADER · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03075553Phase 2 · terminated Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00014235NA · completed Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02652715NA · completed Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03203369Phase 1 · terminated Study to Evaluate the Safety and Clinical Activity of UCART123 in Patients With BPDCN · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00397579Phase 1/Phase 2 · completed DT388IL3 Fusion Protein in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02859623completed Descriptive Study of the Efficacy of Treatments for Blastic Dendritic Cell Neoplasm (BPDCN) · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01231919Phase 1 · completed MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia · condition mapped ONTOLOGY_EXACT · 82 trials mapped (55 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |